Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose ...

its investigational neuroactive pherine nasal spray in Phase 3 development for the acute treatment of social anxiety disorder (SAD). The repeat dose study is a small exploratory U.S. Phase 2 multi ...

It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...

Questions over the extent to which animals can experience mental illness have existed for centuries. Though researchers and ...

As the winter skies become gray and cloud-covered, the winds blow, snow grows by the foot, and the temperatures dip in this two-peninsula state, a portion of Michigan’s 10 million residents face ...

Srinivas RaoM.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn Short, Ph.D.

With unprecedented wildfires sweeping the Los Angeles area, people may face threats not just their physical safety but also ...

Children and young people in LA are experiencing devastating loss, while others are watching in horror from afar. Experts ...

But while the feelings that accompany such moments have been a boon to Taylor Swift and the rest of the music industry, a ...

The brain controls many aspects of thinking — remembering, planning and organizing, making decisions, and much more. These ...